Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.

Publication Type:

Journal Article


Antiviral therapy, Volume 13, Issue 6, p.799-807 (2008)


2008, Adult, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Female, HIV Infections, HIV Seropositivity, HIV-1, Human Biology Division, Humans, Infant, Newborn, Infectious Disease Transmission, Vertical, Lamivudine, Milk, Human, Nevirapine, PREGNANCY, Pregnancy Complications, Infectious, Public Health Sciences Division, RNA, Viral, Treatment Outcome, Zidovudine


Defining the effect of antiretroviral regimens on breast milk HIV type-1 (HIV-1) levels is useful to inform the rational design of strategies to decrease perinatal HIV-1 transmission.